Peptides
Kallikrein-2 inhibitor, cyclic (KLK2b ht4) -1mg
€240.00
Check your price
- Cat.Number : AS-65652
- Manufacturer Ref. :
-
Availability :
In production
KLK2b ht4, a head to tail cyclic peptide, is an inhibitor of human glandular kallikrein enzyme, kallikrein-2 (KLK2). This enzyme belongs to kallikreins, serine protease family, which comprises of 15 members (KLK1-KLK15). KLK2 is increased in tumor tissues and in serum of patients with prostate cancer and is considered as a biomarker for this type of cancer.
Inhibition of KLK2 activity might be a promising therapy for prostate cancer. KLK2b ht4 cyclic peptide shows higher stability and biological activity compared with linear peptide inhibitors.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Storage Conditions |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Codes | |
| Code Nacres |
|
Downloads
You may also be interested in the following product(s)
SensoLyte® Rh110 Plasma Kallikrein Activity Assay Kit Fluorimetric - 1 kit
Cat.Number :
AS-72255
€607.00
Excl. Tax